Live icon Substance Use Disorder Training Recorded Training Event

Patient Centered Treatment for Substance Use Disorder in Primary Care

Patient Centered Treatment for Substance Use Disorder in Primary Care – Recorded (On Demand) Training

Supporting patient-centered treatment of substance use disorder

This 12-module series provides practical guidance to care teams seeking to elevate the level of care provided to patients with substance use disorder (SUD). The odd-numbered modules in this series are focused on clinical best practices. The even-numbered modules in this series are focused on operational aspects of office-based addiction treatment (OBAT) and include interviews from practice, where practices who have implemented the materials covered in that module provide testimonials via brief interviews.

All 12 modules are available on-demand and can be completed in the order and at the pace that best fits the learning needs of the individual and their practice.

Participants of this module series will also have access to:

  1. A complementary toolkit that provides access to additional supportive resources.
  2. Live coaching and mentoring sessions.

Sessions

Session#1: Navigating Buprenorphine Prescribing for the PCP

This session is designed to outline a patient-centered approach to diagnosis of opioid use disorder and buprenorphine prescribing.

Participate in this training session by clicking here!

Session#2: Substance Use Disorder and Patient Identification

This session is designed to guide the participant through implementation of screening and patient identification procedures for substance use disorder.

Participate in this training session by clicking here!

Session#3: Buprenorphine Medical Management: Monitoring the Patient

This session is designed to outline best practices associated with drug testing for monitoring patients with substance use disorder.

Participate in this training session by clicking here!

Session#4: OBAT Eligibility, Intake and Assessment

This session is designed to guide the participant through developing in-office procedures for screening and intake into an OBAT program and the initial provider assessment.

Participate in this training session by clicking here!

Session#5: Challenging Clinical Scenarios in MOUD: Early Refills and Lost or Stolen Medication

This session is designed to  outline best practices for responding to challenging clinical scenarios, including requests for early refills and patient-reported lost of stolen medications.

Participate in this training session by clicking here!

Session#6: Patient Support for Induction and Maintenance

This session is designed to provide guidance on implementation of office-based induction and maintenance of buprenorphine using the OBAT model.

Participate in this training session by clicking here!

Session#7: Complex Cases in Buprenorphine Treatment Part 1

This session is designed to provide the opportunity for review and consideration of specific patient cases from practice, including those related to co-occurring alcohol use disorder.

Participate in this training session by clicking here!

Session#8: Operationalizing Team Meetings, Systematic Case Review & Documentation

This session is designed to review best practices related to interprofessional communication, team meetings, and documentation.

Participate in this training session by clicking here!

Session#9: Complex Cases in Buprenorphine Treatment Part 2

This session is designed to provide the opportunity for review and consideration of specific patient cases from practice, including those related to substance use disorder in pregnancy.

Participate in this training session by clicking here!

Session#10: Team Roles and Responsibilities

This session is designed to describe roles and responsibilities of team members engaged in OBAT.

Participate in this training session by clicking here!

Session#11: Pain and Addiction

This session is designed to review approaches to managing co-occurring pain and substance use disorder, including application to individual patient cases.

Participate in this training session by clicking here!

Session#12: Supporting the Patient Beyond Buprenorphine

This session is designed to describe key opportunities to support a patient with substance use disorder, including care coordination, services and interventions, and problem solving related to special populations and complex situations.

Participate in this training session by clicking here!

Audience

This series is intended for providers, nurses, social workers, medical assistants, community health works, and other care team members who are seeking to expand their knowledge and skills.

Faculty

Edward Jouney, D.O., M.S.

Dr. Jouney is an addiction psychiatrist and forensic psychiatric fellow at the Center for Forensic Psychiatry at Michigan Medicine in the Department of Psychiatry. He is a consulting psychiatrist at the UM High-Risk OB Clinic and has successfully trained in Addiction Psychiatry at the University of Michigan. Dr. Jouney received his D.O. degree at Michigan State University, College of Osteopathic Medicine, and completed residency training in Psychiatry at the University of Michigan. He is a member of the American Society of Addiction Medicine (ASAM) and the American Academy of Addiction Psychiatry. Dr. Jouney serves on the University of Michigan Health System Controlled Substance Quality Improvement Committee.

View Bio

Claire Nolan, PharmD

Claire Nolan received her Doctor of Pharmacy degree from the Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences in Detroit, MI. Dr. Nolan has experience in the specialty, ambulatory, and community pharmacy practice settings. She has focused her career on continuous quality improvement, program development, and education.

View Bio

Robin Schreur, BS, RN, CCM

Robin Schreur is a trainer for the Michigan Center for Clinical Systems Improvement (Mi-CCSI). She served as the Clinical Lead Care Manager in Ambulatory Care at Spectrum Health from 2012 until 2020. Her aim is to instill the importance of patient-centered care across the continuum of care. Robin has worked in a variety of settings including insurance-based and primary care practices, and as a behavioral health nurse at an inpatient facility. She has extensive experience in training and onboarding hundreds of clinicians in care management roles and motivational interviewing.

View Bio

Cost

Cost is per session and may be paid by credit card through PayPal.

Session#1: $25 for members; $25 for non-members
Session#2: $25 for members; $25 for non-members
Session#3: $25 for members; $25 for non-members
Session#4: $25 for members; $25 for non-members
Session#5: $25 for members; $25 for non-members
Session#6: $25 for members; $25 for non-members
Session#7: $25 for members; $25 for non-members
Session#8: $25 for members; $25 for non-members
Session#9: $25 for members; $25 for non-members
Session#10: $25 for members; $25 for non-members
Session#11: $25 for members; $25 for non-members
Session#12: $25 for members; $25 for non-members
$25 for members; $25 for non-members

CONTINUING EDUCATION CREDITS

Providers & Nurses

AAFP:
The AAFP has reviewed Patient Centered Treatment for Substance Use Disorder in Primary Care, and deemed it acceptable for AAFP credit. Term of approval is from 09/01/2021 to 08/31/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit approval includes the following sessions:

  • 2.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Navigating Buprenorphine Prescribing for the Primary Care Provider
  • 1.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – SUD and patient identification
  • 2.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Use of Buprenorphine: monitoring the patient
  • 1.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Patient support for induction and maintenance
  • 2.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Use of Buprenorphine in OUD Part 1
  • 1.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – OBAT Eligibility: Intake and Assessment
  • 2.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Use of Buprenorphine in OUD Part 2
  • 1.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Operationalizing Team Meetings & Systematic Case Review
  • 2.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Challenging Scenarios in MOUD
  • 1.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Team roles and responsibilities: Office Operations to Support the Prescribing Provider
  • 2.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Managing coexisting conditions: Pain and Addiction
  • 1.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Supporting the patient beyond Buprenorphine

AMA/AAFP Equivalency:
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
Nurses:
Note: Nurses can use CME credits toward re-licensure.
Michigan Board of Nursing Continuing Education Requirements Details

Social Workers

This course is approved by the NASW-Michigan Social Work Continuing Education Collaborative
Approval #: 081321-00

The course, when completed in full (participating in all sessions) is approved for a maximum of 18 contact hours.

Training Materials & Course Preparation

Course materials including the series toolkit and additional tools are found here.

Questions

If you have any questions, contact Amy at amy.wales@miccsi.org

Click to view other Recorded (On-Demand) Trainings

Register icon
Session#1: Navigating Buprenorphine Prescribing for the PCP

Participate Now!

Register icon
Session#2: Substance Use Disorder and Patient Identification

Participate Now!

Register icon
Session#3: Buprenorphine Medical Management: Monitoring the Patient

Participate Now!

Register icon
Session#4: OBAT Eligibility, Intake and Assessment

Participate Now!

Register icon
Session#5: Challenging Clinical Scenarios in MOUD: Early Refills and Lost or Stolen Medication

Participate Now!

Register icon
Session#6: Patient Support for Induction and Maintenance

Participate Now!

Register icon
Session#7: Complex Cases in Buprenorphine Treatment Part 1

Participate Now!

Register icon
Session#8: Operationalizing Team Meetings, Systematic Case Review & Documentation

Participate Now!

Register icon
Session#9: Complex Cases in Buprenorphine Treatment Part 2

Participate Now!

Register icon
Session#10: Team Roles and Responsibilities

Participate Now!

Register icon
Session#11: Pain and Addiction

Participate Now!

Register icon
Session#12: Supporting the Patient Beyond Buprenorphine

Participate Now!

Cost

Session#1:
Members

$25

Non-Members

$25


Session#2:
Members

$25

Non-Members

$25


Session#3:
Members

$25

Non-Members

$25


Session#4:
Members

$25

Non-Members

$25


Session#5:
Members

$25

Non-Members

$25


Session#6:
Members

$25

Non-Members

$25


Session#7:
Members

$25

Non-Members

$25


Session#8:
Members

$25

Non-Members

$25


Session#9:
Members

$25

Non-Members

$25


Session#10:
Members

$25

Non-Members

$25


Session#11:
Members

$25

Non-Members

$25


Session#12:
Members

$25

Non-Members

$25


Cost is per session and may be paid by credit card through PayPal.

Welcome! We’ve recently made some changes to our website and would love to hear what you think! If you have any feedback, please send it to Amy Wales @ amy.wales@miccsi.org.

Welcome! We’ve recently made some changes to our website and would love to hear what you think! If you have any feedback, please send it to Amy Wales @ amy.wales@miccsi.org.